Cargando…
SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke
BACKGROUND: Neural stem cell (NSC)-based therapies hold great promise for treating diseases of the central nervous system (CNS). However, several fundamental problems still need to be overcome to fully exploit the clinical potential of NSC therapeutics. Chief among them is the limited survival of NS...
Autores principales: | Bernstock, Joshua D., Peruzzotti-Jametti, Luca, Leonardi, Tommaso, Vicario, Nunzio, Ye, Daniel, Lee, Yang-ja, Maric, Dragan, Johnson, Kory R., Mou, Yongshan, Van Den Bosch, Aletta, Winterbone, Mark, Friedman, Gregory K., Franklin, Robin J.M., Hallenbeck, John M., Pluchino, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491415/ https://www.ncbi.nlm.nih.gov/pubmed/30905846 http://dx.doi.org/10.1016/j.ebiom.2019.03.035 |
Ejemplares similares
-
Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming
por: Bernstock, Joshua D., et al.
Publicado: (2017) -
A novel quantitative high-throughput screen identifies drugs that
both activate SUMO conjugation via the inhibition of microRNAs 182 and 183 and
facilitate neuroprotection in a model of oxygen and glucose
deprivation
por: Bernstock, Joshua D, et al.
Publicado: (2015) -
Global SUMOylation is a molecular mechanism underlying hypothermia-induced ischemic tolerance
por: Lee, Yang-ja, et al.
Publicado: (2014) -
Elevated Global SUMOylation in Ubc9 Transgenic Mice Protects Their Brains against Focal Cerebral Ischemic Damage
por: Lee, Yang-ja, et al.
Publicado: (2011) -
Drugging SUMOylation for neuroprotection and oncotherapy
por: Bernstock, Joshua D., et al.
Publicado: (2018)